Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Emory University
Study ID
NCT06595160
Status
Recruiting
Apply to this trial

Conditions

  • Borderline Resectable Pancreatic Ductal Adenocarcinoma
  • Resectable Pancreatic Ductal Adenocarcinoma
  • Stage I Pancreatic Cancer AJCC v8

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study explores the relationship between pre-treatment dietary patterns, fecal microbiome, and response to chemotherapy in patients with pancreatic ductal adenocarcinoma.

Key Dates

Start date
Aug 5, 2024
Status verified
Jul 2025
Primary completion
Apr 30, 2026
Completion
Aug 7, 2027

Study Design

Enrollment
87 participants (estimated)

Arms

  • Arm: Observational
    Patients complete a dietary survey and undergo fecal sample collection on study.

Primary Outcome Measure

Fecal Microbiome Alpha Diversity [ Time Frame: Through study completion, an average of two years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Emory University Hospital/Winship Cancer InstituteAtlantaGeorgia30322
Mihir M. Shah
[email protected]
404-778-3307
Mihir M. Shah (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlanta, GA

By research site
Emory University Hospital/Winship Cancer Institute· Atlanta, GA

Related Studies